NFLPA Calls for Full Investigation Into Jalen Hurts' Blood Clots

The NFL Players Association is calling on the National Football League to conduct a full investigation into the medical care provided to Philadelphia Eagles quarterback Jalen Hurts after the player was diagnosed with multiple blood clots that sidelined him for the remainder of the season. In a statement released on Monday, the union emphasized that determining the facts of the case is essential to ensuring players receive the highest level of care and protection going forward.

Hurts' medical ordeal began following a Week 4 game against the Los Angeles Rams on October 4, when he sustained a calf injury after taking a cleat to the leg. He was initially diagnosed by specialists in London with a superficial vein thrombosis following an ultrasound after team practice on October 10. Despite the diagnosis, medical staff in London and the Eagles organization determined that mobility and activity were safe, allowing Hurts to play in the team's matchup against the Jacksonville Jaguars.

Following the game in London, Hurts flew back to the United States and was placed on the injured reserve list. Subsequent testing revealed that the condition had progressed. The Eagles and the quarterback's agent, Nicole Lynn, released a joint statement announcing that the condition had developed into a deep vein thrombosis as well as bilateral pulmonary emboli, meaning clots had traveled to both of his lungs.

The situation has sparked intense debate regarding the decision to clear Hurts to play and fly shortly after his initial diagnosis. Reports indicated that Hurts spent time at a London clinic until the early morning hours prior to the game. However, the player's agent later clarified that he was instructed to rest upon returning to the team hotel, and the Eagles provided a private space at the stadium for him to rest before kickoff.

While criticism has been leveled at the team's medical staff by outside experts, top NFL officials have strongly defended the handling of the case. NFL Chief Medical Officer Dr. Allen Sills described the decisions made by the medical staff as conservative, patient-focused, and vigilant. Sills stated at the league's fall meeting that he has complete confidence in the Eagles' medical team, noting that sometimes medical conditions progress despite appropriate care. Jeff Miller, the NFL's executive vice president for player health and safety, echoed those remarks, stating that Hurts' health was always the top priority.

Despite the league's defense, the NFLPA maintains that no formal league investigation into the matter has taken place, noting that the union was previously informed that the league did not plan to review the care provided. The union's demand for transparency highlights ongoing concerns regarding player health and safety protocols across professional football.

Hurts is currently undergoing treatment involving blood thinners and will not be permitted to participate in any football activities until he is cleared. According to team updates, he is clinically stable, has no significant functional limitations, and is expected to make a full recovery without long-term effects. Meanwhile, the Eagles continue to navigate the season without their starting quarterback as they work to overcome a slow start and numerous roster injuries.